Distinguishing gastrointestinal stromal tumors from their mimics: An update

Advances in Anatomic Pathology

Volumn 14, Issue 3, 2007, Pages 178-188

  Abraham, Susan C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Desmoid; Gastrointestinal stromal tumor; GIST; Inflammatory fibroid polyp; Leiomyoma; Leiomyosarcoma; Schwannoma; Solitary fibrous tumor

Indexed keywords

DESMOID TUMOR; FOLLICULAR DENDRITIC CELL; GASTROINTESTINAL STROMAL TUMOR; GLOMUS TUMOR; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; LIPOSARCOMA; MESENTERITIS; MUSCLE TUMOR; NEURILEMOMA; NEUROBLASTOMA; PRIORITY JOURNAL; REVIEW; SARCOMA; SOLITARY FIBROUS TUMOR; TISSUE SECTION; TUMOR LOCALIZATION; TUMOR VOLUME;

DIAGNOSIS, DIFFERENTIAL; FIBROMA; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; NEURILEMMOMA; POLYPS; SMOOTH MUSCLE TUMOR; STEM CELL FACTOR;

EID: 34247491487     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e318050aa66     Document Type: Review

References (55)

1. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577-580.
2. Nishida T, Hirota S, Taniguchi M, et al. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet. 1998;19:323-324.
3. Rubin PB. Gastrointestinal stromal tumours: an update. Histopathology. 2006;48:83-96.
4. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med. 2001;344:1052-1056.
5. Hosalkar HS, Fox EJ, Delaney T, et al. Desmoid tumors and current status of management. Orthop Clin North Am. 2006;37:53-63.
6. Rodriguez JA, Guarda LA, Rosai J. Mesenteric fibromatosis with involvement of the gastrointestinal tract. A GIST simulator: a study of 25 cases. Am J Clin Pathol. 2004;121:93-98.
7. Yantiss RK, Spiro IJ, Compton CC, et al. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall. A clinically important differential diagnosis. Am J Surg Pathol. 2000;24:947-957.
8. Miettinen M, Monihan JM, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999;23:1109-1118.
9. Latchford AR, Sturt NJ, Neale K, et al. A 10-year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br J Surg. 2006;93:1258-1264.
10. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. 2006;101:385-398.
11. Alman BA, Li C, Pajerski ME, et al. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol. 1997;151:329-334.
12. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene. 1999;18:6615-6620.
13. Montgomery E, Torbenson MS, Kaushal M, et al. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol. 2002;26:1296-1301.
14. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol. 2005;29:653-659.
15. Miettinen M. Are desmoid tumors KIT positive? Am J Surg Pathol. 2001;25:549-550.
16. Leithner A, Gapp M, Radl R, et al. Immunohistochemical analysis of desmoid tumors. J Clin Pathol. 2005;58:1152-1156.
17. Hornick JL, Fletcher CD. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol. 2002;117:188-193.
18. Lucas DR, al-Abbadi M, Tabaczka P, et al. c-Kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol. 2003;119:339-345.
19. Yamaguchi U, Hasegawa T, Masuda T, et al. Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis. Virchows Arch. 2004;445:142-150.
20. Miettinen M, Sobin LH, Lasota JL. Gastrointestinal stromal tumors of the stomach. A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52-68.
21. Miettinen M, Kopczynski J, Makhlouf H, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum. A clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol. 2003;27:625-641.
22. Miettinen M, Kopczynski J, Sobin LH, et al. Gastrointestinal stromal tumors of the jejunum and ileum. A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 2006;30:477-489.
23. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al. Gastrointestinal stromal tumors and leiomyosarcomas in the colon. A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol. 2000;24:1339-1352.
24. Miettinen M, Furlong M, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus. A clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol. 2001;25:1121-1133.
25. Heinrich MC, McArthur GA, Demetri GD, et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol. 2006;24:1195-1203.
26. Miettinen M, Sarlomo-Rikala M, Sobin LH. Mesenchymal tumors of muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors - a clinicopathologic and immunohistochemical study of eighty-eight cases. Mod Pathol. 2001;14:950-956.
27. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al. Esophageal stromal tumors. A clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2000;24:211-222.
28. Abraham SC, Krasinskas AM, Hofstetter WL, et al. "Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction. Am J Surg Pathol. In press.
29. Mutrie CJ, Donahue DM, Wain JC, et al. Esophageal leiomyoma: a 40-year experience. Ann Thorac Surg. 2005;79:1122-1125.
30. Agaimy A, Wunsch PH. Sporadic Cajal cell hyperplasia is common in resection specimens for distal oesophageal carcinoma. A retrospective review of 77 consecutive surgical resection specimens. Virchows Arch. 2006;448:288-294.
31. Cheng BC, Chang S, Mao ZF, et al. Surgical treatment of giant esophageal leiomyoma. World J Gastroenterol. 2005;11:4258-4260.
32. Zaninotto G, Portale G, Costantini M, et al. Minimally invasive enucleation of esophageal leiomyoma. Surg Endosc. 2006 [Epub].
33. Rahili A, D'Amata G, Avallone S, et al. Concomitant leiomyoma and leiomyosarcoma of the oesophagus. J Exp Clin Cancer Res. 2005;24:487-491.
34. Aiko S, Yoshizumi Y, Sugiura Y, et al. Pedunculated esophageal leiomyosarcoma: a case report. Dis Esophagus. 1998;11:263-267.
35. Meza-Zepeda LA, Kresse SH, Barragan-Polania AH, et al. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res. 2006;66:8984-8993.
36. Kwon MS, Lee SS, Ahn GH. Schwannomas of the gastrointestinal tract: clinicopathological features of 12 cases including a case of esophageal tumor compared with those of gastrointestinal stromal tumors and leiomyomas of the gastrointestinal tract. Pathol Res Pract. 2002;198:605-613.
37. Miettinen M, Shekitka KM, Sobin LH. Schwannomas in the colon and rectum. A clinicopathologic and immunohistochemical study of 20 cases. Am J Surg Pathol. 2001;25:846-855.
38. Park BJ, Carrasquillo J, Bains MS, et al. Giant benign esophageal schwannoma requiring esophagectomy. Ann Thorac Surg. 2006;82:340-342.
39. Hou YY, Tan YS, Xu JF, et al. Schwannoma of the gastrointestinal tract: a clinicopathological, immunohistochemical, and ultrastructural study of 33 cases. Histopathology. 2006;48:536-545.
40. Prevot S, Bienvenu L, Vaillant JC, et al. Benign schwannoma of the digestive tract: a clinicopathologic and immunohistochemical study of five cases, including a case of esophageal tumor. Am J Surg Pathol. 1999;23:431-436.
41. Daimaru Y, Kido H, Hashimoto H, et al. Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study. Hum Pathol. 1998;19:257-264.
42. Arai T, Sugimura H, Suzuki M, et al. Benign schwannoma of the esophagus: report of two cases with immunohistochemical and ultrastructural studies. Pathol Int. 1994;44:460-465.
43. Lasota J, Wasag B, Dansonka-Mieszkowska A, et al. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: a study of 20 cases. Lab Invest. 2003;83:1361-1371.
44. Sarlomo-Rikala M, Miettinen M. Gastric schwannoma - a clinicopathological analysis of six cases. Histopathology. 1995;27:355-360.
45. Matsushita M, Hajiro K, Okazaki K, et al. Endoscopic features of gastric inflammatory fibroid polyps. Am J Gastroenterol. 1996;91:1595-1598.
46. Pantanowitz L, Antonioli DA, Pinkus GS, et al. Inflammatory fibroid polyps of the gastrointestinal tract: evidence for a dendritic cell origin. Am J Surg Pathol. 2004;28:107-114.
47. Wille P, Borchard F. Fibroid polyps of intestinal tract are inflammatory-reactive proliferations of CD34-positive perivascular cells. Histopathology. 1998;32:498-502.
48. Hasegawa T, Yang P, Kagawa N, et al. CD34 expression by inflammatory fibroid polyps of the stomach. Mod Pathol. 1997;10:451-456.
49. Ozolek JA, Sasatomi E, Swalsky PA, et al. Inflammatory fibroid polyps of the gastrointestinal tract: clinical, pathologic, and molecular characteristics. Appl Immunohistochem Mol Morphol. 2004;12:59-66.
50. Levy AD, Rimola J, Mehrotra AK, et al. From the archives of the AFIP: benign fibrous tumors and tumorlike lesions of the mesentery: radiologic-pathologic correlation. Radiographics. 2006;26:245-264.
51. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol. 2000;13:1134-1142.
52. de Parrot M, Kurt AM, Robert JH, et al. Clinical behavior of solitary fibrous tumors of the pleura. Ann Thorac Surg. 1999;67:1456-1459.
53. Shidham VB, Chivukula M, Gupta D, et al. Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor. Arch Pathol Lab Med. 2002;126:1189-1192.
54. Rossi G, Valli R, Bertolini F, et al. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract. Histopathology. 2005;46:522-531.
55. Yamaguchi U, Hasegawa T, Sakurai S, et al. Interobserver variability in histologic recognition, interpretation of KIT immunostaining, and determining MIB-1 labeling indices in gastrointestinal stromal tumors and other spindle cell tumors of the gastrointestinal tract. Appl Immunohistochem Mol Morphol. 2006;14:46-51.